521 related articles for article (PubMed ID: 30959825)
1. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
Casey JL; Feld JJ; MacParland SA
Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
[TBL] [Abstract][Full Text] [Related]
2. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection.
Casey JL; Dore GJ; Grebely J; Matthews GV; Cherepanov V; Martinello M; Marks P; Janssen HLA; Hansen BE; Kaul R; MacParland SA; Gehring AJ; Feld JJ
J Viral Hepat; 2023 Jan; 30(1):64-72. PubMed ID: 36302162
[TBL] [Abstract][Full Text] [Related]
4. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
5. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance.
Zhang C; Hua R; Cui Y; Wang S; Yan H; Li D; Zhang Y; Tu Z; Hao P; Chen X; Zhong J; Niu J; Jin X
PLoS One; 2017; 12(2):e0171217. PubMed ID: 28170421
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus.
Khanam A; Kottilil S; Wilson E
Sci Rep; 2020 Nov; 10(1):19924. PubMed ID: 33199783
[TBL] [Abstract][Full Text] [Related]
8. Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.
Burchill MA; Golden-Mason L; Wind-Rotolo M; Rosen HR
J Viral Hepat; 2015 Dec; 22(12):983-91. PubMed ID: 26482547
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.
Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA;
J Gastroenterol Hepatol; 2013 Nov; 28(11):1770-81. PubMed ID: 23663030
[TBL] [Abstract][Full Text] [Related]
10. Restoration of HCV-specific CD8+ T cell function by interferon-free therapy.
Martin B; Hennecke N; Lohmann V; Kayser A; Neumann-Haefelin C; Kukolj G; Böcher WO; Thimme R
J Hepatol; 2014 Sep; 61(3):538-43. PubMed ID: 24905492
[TBL] [Abstract][Full Text] [Related]
11. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.
Larrubia JR; Moreno-Cubero E; Miquel J; Sanz-de-Villalobos E
World J Gastroenterol; 2015 Mar; 21(12):3480-91. PubMed ID: 25834312
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation.
Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Otsuka S; Ohnami S; Nagashima T; Hatakeyama K; Kakuda Y; Sugino T; Urakami K; Akiyama Y; Yamaguchi K
Cancer Med; 2022 Apr; 11(8):1769-1786. PubMed ID: 35174643
[TBL] [Abstract][Full Text] [Related]
14. Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Lens S; Leonel T; Bartres C; García-López M; Rodriguez-Tajes S; Forns X; Koutsoudakis G
J Viral Hepat; 2020 Dec; 27(12):1408-1418. PubMed ID: 32812325
[TBL] [Abstract][Full Text] [Related]
15. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
16. Effect of Direct Acting Antivirals (DAAs) on Myeloid-Derived Suppressor Cells Population in Egyptian Chronic Hepatitis C Virus Patients: A Potential Immunomodulatory Role of DAAs.
Abdulsamad B; Afifi M; Awaad AK; Elbendary W; Mustafa H; Elsherbini B
Viral Immunol; 2023 May; 36(4):259-267. PubMed ID: 36802279
[TBL] [Abstract][Full Text] [Related]
17. Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8
Vranjkovic A; Deonarine F; Kaka S; Angel JB; Cooper CL; Crawley AM
Front Immunol; 2019; 10():1926. PubMed ID: 31456810
[TBL] [Abstract][Full Text] [Related]
18. Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon.
Mascia C; Vita S; Zuccalà P; Marocco R; Tieghi T; Savinelli S; Rossi R; Iannetta M; Pozzetto I; Furlan C; Mengoni F; Mastroianni CM; Vullo V; Lichtner M
PLoS One; 2017; 12(6):e0179400. PubMed ID: 28636655
[TBL] [Abstract][Full Text] [Related]
19. HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
Bruno G; Saracino A; Scudeller L; Fabrizio C; Dell'Acqua R; Milano E; Milella M; Ladisa N; Monno L; Angarano G
Int J Infect Dis; 2017 Sep; 62():64-71. PubMed ID: 28728927
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
Li H; Huang MH; Jiang JD; Peng ZG
World J Gastroenterol; 2018 Dec; 24(47):5297-5311. PubMed ID: 30598575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]